Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neuroscience Market, by Component
1.4.2 Global Neuroscience Market, by Technology
1.4.3 Global Neuroscience Market, by End User
1.4.4 Global Neuroscience Market, by Geography
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Oct– 2023, Jul) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Global Neuroscience Market by Component
5.1 Global Instruments Market by Region
5.2 Global Consumables Market by Region
5.3 Global Software & Services Market by Region
Chapter 6. Global Neuroscience Market by Technology
6.1 Global Brain Imaging Market by Region
6.2 Global Stereotaxic Surgeries Market by Region
6.3 Global Neuro-Microscopy Market by Region
6.4 Global Neuro-Proteomic Analysis Market by Region
6.5 Global Neuro-Cellular Manipulation Market by Region
6.6 Global Others Market by Region
Chapter 7. Global Neuroscience Market by End User
7.1 Global Diagnostic Laboratories Market by Region
7.2 Global Hospitals Market by Region
7.3 Global Research & Academic Institute Market by Region
Chapter 8. Global Neuroscience Market by Region
8.1 North America Neuroscience Market
8.1.1 North America Neuroscience Market by Component
8.1.1.1 North America Instruments Market by Country
8.1.1.2 North America Consumables Market by Country
8.1.1.3 North America Software & Services Market by Country
8.1.2 North America Neuroscience Market by Technology
8.1.2.1 North America Brain Imaging Market by Country
8.1.2.2 North America Stereotaxic Surgeries Market by Country
8.1.2.3 North America Neuro-Microscopy Market by Country
8.1.2.4 North America Neuro-Proteomic Analysis Market by Country
8.1.2.5 North America Neuro-Cellular Manipulation Market by Country
8.1.2.6 North America Others Market by Country
8.1.3 North America Neuroscience Market by End User
8.1.3.1 North America Diagnostic Laboratories Market by Country
8.1.3.2 North America Hospitals Market by Country
8.1.3.3 North America Research & Academic Institute Market by Country
8.1.4 North America Neuroscience Market by Country
8.1.4.1 US Neuroscience Market
8.1.4.1.1 US Neuroscience Market by Component
8.1.4.1.2 US Neuroscience Market by Technology
8.1.4.1.3 US Neuroscience Market by End User
8.1.4.2 Canada Neuroscience Market
8.1.4.2.1 Canada Neuroscience Market by Component
8.1.4.2.2 Canada Neuroscience Market by Technology
8.1.4.2.3 Canada Neuroscience Market by End User
8.1.4.3 Mexico Neuroscience Market
8.1.4.3.1 Mexico Neuroscience Market by Component
8.1.4.3.2 Mexico Neuroscience Market by Technology
8.1.4.3.3 Mexico Neuroscience Market by End User
8.1.4.4 Rest of North America Neuroscience Market
8.1.4.4.1 Rest of North America Neuroscience Market by Component
8.1.4.4.2 Rest of North America Neuroscience Market by Technology
8.1.4.4.3 Rest of North America Neuroscience Market by End User
8.2 Europe Neuroscience Market
8.2.1 Europe Neuroscience Market by Component
8.2.1.1 Europe Instruments Market by Country
8.2.1.2 Europe Consumables Market by Country
8.2.1.3 Europe Software & Services Market by Country
8.2.2 Europe Neuroscience Market by Technology
8.2.2.1 Europe Brain Imaging Market by Country
8.2.2.2 Europe Stereotaxic Surgeries Market by Country
8.2.2.3 Europe Neuro-Microscopy Market by Country
8.2.2.4 Europe Neuro-Proteomic Analysis Market by Country
8.2.2.5 Europe Neuro-Cellular Manipulation Market by Country
8.2.2.6 Europe Others Market by Country
8.2.3 Europe Neuroscience Market by End User
8.2.3.1 Europe Diagnostic Laboratories Market by Country
8.2.3.2 Europe Hospitals Market by Country
8.2.3.3 Europe Research & Academic Institute Market by Country
8.2.4 Europe Neuroscience Market by Country
8.2.4.1 Germany Neuroscience Market
8.2.4.1.1 Germany Neuroscience Market by Component
8.2.4.1.2 Germany Neuroscience Market by Technology
8.2.4.1.3 Germany Neuroscience Market by End User
8.2.4.2 UK Neuroscience Market
8.2.4.2.1 UK Neuroscience Market by Component
8.2.4.2.2 UK Neuroscience Market by Technology
8.2.4.2.3 UK Neuroscience Market by End User
8.2.4.3 France Neuroscience Market
8.2.4.3.1 France Neuroscience Market by Component
8.2.4.3.2 France Neuroscience Market by Technology
8.2.4.3.3 France Neuroscience Market by End User
8.2.4.4 Russia Neuroscience Market
8.2.4.4.1 Russia Neuroscience Market by Component
8.2.4.4.2 Russia Neuroscience Market by Technology
8.2.4.4.3 Russia Neuroscience Market by End User
8.2.4.5 Spain Neuroscience Market
8.2.4.5.1 Spain Neuroscience Market by Component
8.2.4.5.2 Spain Neuroscience Market by Technology
8.2.4.5.3 Spain Neuroscience Market by End User
8.2.4.6 Italy Neuroscience Market
8.2.4.6.1 Italy Neuroscience Market by Component
8.2.4.6.2 Italy Neuroscience Market by Technology
8.2.4.6.3 Italy Neuroscience Market by End User
8.2.4.7 Rest of Europe Neuroscience Market
8.2.4.7.1 Rest of Europe Neuroscience Market by Component
8.2.4.7.2 Rest of Europe Neuroscience Market by Technology
8.2.4.7.3 Rest of Europe Neuroscience Market by End User
8.3 Asia Pacific Neuroscience Market
8.3.1 Asia Pacific Neuroscience Market by Component
8.3.1.1 Asia Pacific Instruments Market by Country
8.3.1.2 Asia Pacific Consumables Market by Country
8.3.1.3 Asia Pacific Software & Services Market by Country
8.3.2 Asia Pacific Neuroscience Market by Technology
8.3.2.1 Asia Pacific Brain Imaging Market by Country
8.3.2.2 Asia Pacific Stereotaxic Surgeries Market by Country
8.3.2.3 Asia Pacific Neuro-Microscopy Market by Country
8.3.2.4 Asia Pacific Neuro-Proteomic Analysis Market by Country
8.3.2.5 Asia Pacific Neuro-Cellular Manipulation Market by Country
8.3.2.6 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Neuroscience Market by End User
8.3.3.1 Asia Pacific Diagnostic Laboratories Market by Country
8.3.3.2 Asia Pacific Hospitals Market by Country
8.3.3.3 Asia Pacific Research & Academic Institute Market by Country
8.3.4 Asia Pacific Neuroscience Market by Country
8.3.4.1 China Neuroscience Market
8.3.4.1.1 China Neuroscience Market by Component
8.3.4.1.2 China Neuroscience Market by Technology
8.3.4.1.3 China Neuroscience Market by End User
8.3.4.2 Japan Neuroscience Market
8.3.4.2.1 Japan Neuroscience Market by Component
8.3.4.2.2 Japan Neuroscience Market by Technology
8.3.4.2.3 Japan Neuroscience Market by End User
8.3.4.3 India Neuroscience Market
8.3.4.3.1 India Neuroscience Market by Component
8.3.4.3.2 India Neuroscience Market by Technology
8.3.4.3.3 India Neuroscience Market by End User
8.3.4.4 South Korea Neuroscience Market
8.3.4.4.1 South Korea Neuroscience Market by Component
8.3.4.4.2 South Korea Neuroscience Market by Technology
8.3.4.4.3 South Korea Neuroscience Market by End User
8.3.4.5 Singapore Neuroscience Market
8.3.4.5.1 Singapore Neuroscience Market by Component
8.3.4.5.2 Singapore Neuroscience Market by Technology
8.3.4.5.3 Singapore Neuroscience Market by End User
8.3.4.6 Malaysia Neuroscience Market
8.3.4.6.1 Malaysia Neuroscience Market by Component
8.3.4.6.2 Malaysia Neuroscience Market by Technology
8.3.4.6.3 Malaysia Neuroscience Market by End User
8.3.4.7 Rest of Asia Pacific Neuroscience Market
8.3.4.7.1 Rest of Asia Pacific Neuroscience Market by Component
8.3.4.7.2 Rest of Asia Pacific Neuroscience Market by Technology
8.3.4.7.3 Rest of Asia Pacific Neuroscience Market by End User
8.4 LAMEA Neuroscience Market
8.4.1 LAMEA Neuroscience Market by Component
8.4.1.1 LAMEA Instruments Market by Country
8.4.1.2 LAMEA Consumables Market by Country
8.4.1.3 LAMEA Software & Services Market by Country
8.4.2 LAMEA Neuroscience Market by Technology
8.4.2.1 LAMEA Brain Imaging Market by Country
8.4.2.2 LAMEA Stereotaxic Surgeries Market by Country
8.4.2.3 LAMEA Neuro-Microscopy Market by Country
8.4.2.4 LAMEA Neuro-Proteomic Analysis Market by Country
8.4.2.5 LAMEA Neuro-Cellular Manipulation Market by Country
8.4.2.6 LAMEA Others Market by Country
8.4.3 LAMEA Neuroscience Market by End User
8.4.3.1 LAMEA Diagnostic Laboratories Market by Country
8.4.3.2 LAMEA Hospitals Market by Country
8.4.3.3 LAMEA Research & Academic Institute Market by Country
8.4.4 LAMEA Neuroscience Market by Country
8.4.4.1 Brazil Neuroscience Market
8.4.4.1.1 Brazil Neuroscience Market by Component
8.4.4.1.2 Brazil Neuroscience Market by Technology
8.4.4.1.3 Brazil Neuroscience Market by End User
8.4.4.2 Argentina Neuroscience Market
8.4.4.2.1 Argentina Neuroscience Market by Component
8.4.4.2.2 Argentina Neuroscience Market by Technology
8.4.4.2.3 Argentina Neuroscience Market by End User
8.4.4.3 UAE Neuroscience Market
8.4.4.3.1 UAE Neuroscience Market by Component
8.4.4.3.2 UAE Neuroscience Market by Technology
8.4.4.3.3 UAE Neuroscience Market by End User
8.4.4.4 Saudi Arabia Neuroscience Market
8.4.4.4.1 Saudi Arabia Neuroscience Market by Component
8.4.4.4.2 Saudi Arabia Neuroscience Market by Technology
8.4.4.4.3 Saudi Arabia Neuroscience Market by End User
8.4.4.5 South Africa Neuroscience Market
8.4.4.5.1 South Africa Neuroscience Market by Component
8.4.4.5.2 South Africa Neuroscience Market by Technology
8.4.4.5.3 South Africa Neuroscience Market by End User
8.4.4.6 Nigeria Neuroscience Market
8.4.4.6.1 Nigeria Neuroscience Market by Component
8.4.4.6.2 Nigeria Neuroscience Market by Technology
8.4.4.6.3 Nigeria Neuroscience Market by End User
8.4.4.7 Rest of LAMEA Neuroscience Market
8.4.4.7.1 Rest of LAMEA Neuroscience Market by Component
8.4.4.7.2 Rest of LAMEA Neuroscience Market by Technology
8.4.4.7.3 Rest of LAMEA Neuroscience Market by End User
Chapter 9. Company Profiles
9.1 Carl Zeiss AG
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.6 SWOT Analysis
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Abbott Laboratories
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Trials and Approvals:
9.3.5.2 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Koninklijke Philips N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Medtronic PLC
9.6.1 Company overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Boston Scientific Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trials and Approvals:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.6 SWOT Analysis
9.9 GE HealthCare Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Stryker Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Product Launches and Product Expansions:
9.10.5.3 Trials and Approvals:
9.10.6 SWOT Analysis
Chapter 10. Winning Imperative for Neuroscience Market
Unique Offerings 
